Actinium Pharmaceuticals, Inc.
ATNM · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$38 | -$49 | -$33 | -$25 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | -$2 |
| Stock-Based Comp. | $5 | $0 | $3 | $2 |
| Change in WC | -$1 | -$3 | $38 | $2 |
| Other Non-Cash | $0 | $4 | -$0 | $2 |
| Operating Cash Flow | -$33 | -$47 | $9 | -$21 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | -$0 |
| Stock Issued | $29 | $15 | $23 | $35 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $29 | $15 | $23 | $35 |
| Forex Effect | $0 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$4 | -$33 | $31 | $14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $77 | $109 | $78 | $64 |
| End Cash | $73 | $77 | $110 | $78 |
| Free Cash Flow | -$33 | -$47 | $8 | -$21 |